Related Experiment Video

Updated: Jun 4, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

A novel oncoprotein Pirh2: rising from the shadow of MDM2

Zhihao Wang1, Bo Yang, Lanlan Dong

  • 1School of Medicine, Wuhan University, Wuhan, China.

Cancer Science
|February 3, 2011
PubMed

Insights

Pirh2 (p53-induced RING-H2) is a key E3 ubiquitin ligase that degrades p53, impacting cancer cell pathways. Understanding Pirh2

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pirh2 (p53-induced RING-H2) is an E3 ubiquitin ligase.
  • Pirh2 targets p53 for degradation, inhibiting p53-regulated cellular activities.
  • Pirh2 is the primary p53 degrader during DNA damage and is highly expressed in various cancer cell lines, irrespective of p53 status.

Purpose of the Study:

  • To provide a comprehensive overview of Pirh2's function in cellular processes.
  • To elucidate Pirh2's significance in cancer development and progression.
  • To explore Pirh2 as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review of Pirh2's role in cellular signaling pathways.
  • Analysis of Pirh2 expression patterns in cancer cell lines.
  • Synthesis of current research on Pirh2's involvement in tumorigenesis.

Main Results:

  • Pirh2 actively degrades p53, influencing diverse biological functions.
  • Pirh2 plays a critical role in the genesis and evolution of cancer.
  • Pirh2 is implicated in numerous cancer-related signaling pathways.

Conclusions:

  • Pirh2 is a significant regulator of p53 stability and activity.
  • Pirh2's dysregulation contributes to cancer development.
  • Targeting Pirh2 presents a promising strategy for novel cancer therapies.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...